stocks to invest in 2018 september
Are you wondering what stocks are a sure thing well that's what your informant is here for !!!
XYO Called XYO, this exciting project has built over 1 million location beacons and is set to disrupt the $11 Trillion dollar location-reliant market
OK, so we're admittedly biased with this one because a core group of our team is behind XYO. But we're not excited about XYO for that reason alone. Actually, some of technology's most influential names are more excited about XYO than we are!
XYO came onto the scene out of nowhere in 2018. In fact, it's still flying a bit under the radar compared to where it could be next year.
Charlie Shrem, tech pioneer and founder of one of its most respected foundations, just recently joined XYO Network.
CNBC called XYO a perfect enterprise play for Amazon, and just recently they grew even closer to the e-commerce giant by joining Amazon Web Services' (AWS) Partner Network.
But what many don't know is they've made an even bigger splash overseas in the Chinese, South Korean and European markets. They've even been featured in massive Chinese Publications, including Forbes China.
So, what makes XYO Network positioned to disrupt the $11 Trillion location-reliant market and create one of the most exciting applications of technology to date?
XYO came onto the scene out of nowhere in 2018. In fact, it's still flying a bit under the radar compared to where it could be next year.
Charlie Shrem, tech pioneer and founder of one of its most respected foundations, just recently joined XYO Network.
CNBC called XYO a perfect enterprise play for Amazon, and just recently they grew even closer to the e-commerce giant by joining Amazon Web Services' (AWS) Partner Network.
But what many don't know is they've made an even bigger splash overseas in the Chinese, South Korean and European markets. They've even been featured in massive Chinese Publications, including Forbes China.
So, what makes XYO Network positioned to disrupt the $11 Trillion location-reliant market and create one of the most exciting applications of technology to date?
Commodity Summary MCX
CRUDE OIL 20-Aug-2018 4602.0019.00 UP
(0.41%)
Crude oil prices turned softer this week amid increasing concerns about slowing global economic growth that could hit demand for petroleum products as inventories build up. NYMEX WTI September contract fell by over 3 per cent this week while ICE Brent Crude October contract fell close to 2 per cent.
Data showing a large build-up in US inventories stoked fears about outlook for fuel demand. The surprise gain in US stockpiles remained fresh in everybody’s mind. Crude inventories increased ..
Read more at:
//economictimes.indiatimes.com/articleshow/65458306.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Data showing a large build-up in US inventories stoked fears about outlook for fuel demand. The surprise gain in US stockpiles remained fresh in everybody’s mind. Crude inventories increased ..
Read more at:
//economictimes.indiatimes.com/articleshow/65458306.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
MIRC Electronics Ltd.
Solid gains by the US stocks in the overnight trade and recovery in Asian markets early Friday helped domestic benchmark indices open with decent gains.
The NSE Nifty index was trading 71 points up at 11,456, while the BSE Sensex was up 249 points at 37,913 around 09:55 am.
Read more at:
//economictimes.indiatimes.com/articleshow/65434580.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
The NSE Nifty index was trading 71 points up at 11,456, while the BSE Sensex was up 249 points at 37,913 around 09:55 am.
Read more at:
//economictimes.indiatimes.com/articleshow/65434580.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Cannabinoid Overview
- The pharmacology of cannabinoids provides significant potential for therapeutics across several diseases that form the core of specialty pharmaceutical drugs.
- Cannabinoid-based pharmaceuticals will emerge as part of the $60 Billion market for pain management in part by displacement of opioid painkillers. By 2024, the market for pain management therapeutics is projected to grow to $83.0 billion.
- Cannabinoids are a class of more than 60 molecules found within Cannabis sativa, and they are the active ingredients in medical marijuana.
- Due to federal restrictions, there traditionally has been a lack of pharmaceutical research dedicated to exploring their medical claims, which has led some to describe cannabinoid research as ‘a neglected pharmacological treasure trove’.
- Cannabis exerts pleiotropic (producing more than one influence; exhibiting multiple expressions) effects on the brain, and medical marijuana has been prescribed for applications ranging from chronic pain, nausea/vomiting, severe anorexia, and muscle spasticity.
- Clinical studies have evaluated effects on chronic pain, neuropathic pain, multiple sclerosis, and many other neurological disorders, with success.